Innovid (NYSE:CTV)’s stock had its “buy” rating reissued by equities research analysts at JMP Securities in a research note issued on Tuesday, TipRanks reports. They presently have a $9.00 price objective on the stock. JMP Securities’ target price would suggest a potential upside of 104.08% from the stock’s current price.
A number of other research firms have also weighed in on CTV. Evercore ISI assumed coverage on shares of Innovid in a report on Friday, December 17th. They issued an “outperform” rating and a $10.00 target price on the stock. BMO Capital Markets decreased their price objective on shares of Innovid from $13.00 to $8.00 and set an “outperform” rating for the company in a research note on Tuesday. Finally, Needham & Company LLC initiated coverage on shares of Innovid in a research note on Tuesday, December 28th. They issued a “buy” rating and a $10.00 price objective for the company.
Shares of CTV traded down $0.22 on Tuesday, reaching $4.41. The company’s stock had a trading volume of 600 shares, compared to its average volume of 87,314. Innovid has a twelve month low of $4.22 and a twelve month high of $10.36. The company has a fifty day moving average of $6.60.
Several institutional investors have recently added to or reduced their stakes in CTV. Segantii Capital Management Ltd bought a new position in shares of Innovid during the 4th quarter valued at approximately $42,000. Qube Research & Technologies Ltd bought a new position in Innovid in the 4th quarter worth approximately $80,000. Migdal Insurance & Financial Holdings Ltd. bought a new position in Innovid in the 4th quarter worth approximately $8,434,000. Phoenix Holdings Ltd. bought a new position in Innovid in the 4th quarter worth approximately $23,537,000. Finally, Ibex Investors LLC bought a new position in Innovid in the 4th quarter worth approximately $13,015,000.
Innovid Company Profile
Innovid Inc provides independent connected TV advertising delivery and measurement platform. Innovid Inc, formerly known as ION Acquisition Corp 2, is based in NEW YORK.